CN103393753A - Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases - Google Patents
Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases Download PDFInfo
- Publication number
- CN103393753A CN103393753A CN2013102973843A CN201310297384A CN103393753A CN 103393753 A CN103393753 A CN 103393753A CN 2013102973843 A CN2013102973843 A CN 2013102973843A CN 201310297384 A CN201310297384 A CN 201310297384A CN 103393753 A CN103393753 A CN 103393753A
- Authority
- CN
- China
- Prior art keywords
- cardiovascular
- traditional chinese
- chinese medicinal
- treatment
- medicinal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and aims to solve the technical problem that a traditional Chinese medicinal composition which is convenient to carry and take and can be used for effectively treating cardiovascular and cerebrovascular diseases is provided. The traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases is characterized by comprising the following raw materials by weight: 0.04-0.07g of bezoar, 0.5-1.5g of scorpion, 0.8-1.2g of pseudo-ginseng, 0.05-0.15g of antelope horn powder, 1-4g of ground beeltle, 0.5-1.5g of red-rooted salvia root, and 0.8-1.6g of suberect spatholobus stem. The traditional Chinese medicinal composition can be used for treating cardiovascular and cerebrovascular diseases, is small in preparation size, small in dosage and small in side effect, and is convenient to carry and take.
Description
Technical field
A kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease of the present invention, belong to the Chinese herbal and crude drugs preparations technical field.
Background technology
Cardiovascular and cerebrovascular disease refers to that sclerosis occurs for heart and arteries and the heart ischemia that causes or hemorrhage disease, comprises that coronary heart diseases and angina pectoris, hypertension, arrhythmia, myocardial infarction, cerebral infarction wait indefinitely.Cardiovascular and cerebrovascular disease is known as the No.1 killer who threatens human health always, and hypertension, hyperlipidemia, coronary heart disease, diabetes become " pestilence in epoch ".
Along with the raising of social life level and the quickening of work rhythm, cardiovascular and cerebrovascular disease has become the leading killer who threatens middle-aged and elderly people healthy and long-lived.According to Ministry of Public Health statistics, the First episode age 1/3 of China's Patients with Cardiovascular/Cerebrovascular Diseases is below 60 years old, and its sickness rate, mortality rate, disability rate, relapse rate are all very high and complication is many: its sickness rate is up to 13.6%, and every day is with 20,000 people's speed increase; Mortality rate, up to 45%, accounts for 50% of total death toll; Disability rate is high, the patient with cerebral apoplexy disability rate up to 75%, patients with coronary artery disease becomes the one able to do light manual labor only; Relapse rate is high, and in cardiovascular and cerebrovascular disease (heart infarction, cerebral infarction) 5 years, relapse rate is up to 42%; The disease of the respiratory system that is caused by cordis and cerebral accident, digestive system, urinary system etc. is more.Wherein hypertension, apoplexy and coronary heart disease are the representative diseases of cardiovascular and cerebrovascular disease.
Hypertension is take the arteriotony rising as feature, with the systemic disease of the organ dysfunctions such as heart, blood vessel, brain and kidney or organic change.In China, the main directly complication of hypertension is cerebrovascular, especially cerebral hemorrhage.In 596 routine senile hypertensions follow-up observation in perspective 27 months research, the heart, cerebrovascular accumulate incidence are 92.79%, and the cerebrovascular accumulate incidence is 76.91%.Research shows, blood pressure is higher, and the incidence rate of complication is also higher.District in Shanghai more than 15 years old 5456 people about the research of blood pressure and stroke onset relation, show, in 9 years of following up a case by regular visits to, patients with hypertension generation cerebrovascular accounts for 70% of whole crowd's cerebrovascular generation number, wherein to suffer from the relative risk of cerebrovascular be 32 times of normotensive subjects to Definite Hypertension, and borderline hypertension is also up to 9 times.Authority survey data show, patients with hypertension myocardial infarction prevalence and coronary heart disease incidence rate are 2.8 times and 3.5 times of normotensive subjects.
Hyperlipidemia, be a kind of common disease, and not only sickness rate is high in the middle of middle-aged and elderly people, and start in recent years " favor " young white collar clan.Hyperlipemia, easily cause " blood is thick ", on blood vessel wall, deposits, and forms atherosclerosis.These deposits increase, increase, and artery-clogging, make blood flow slack-off gradually, and when serious, blood flow is interrupted.If this situation occurs in heart, just cause coronary heart disease; If occur in kidney, will cause renal arteriosclerosis, renal failure; Occur in lower limb, there will be limb necrosis, fester etc.In addition, hyperlipidemia can cause hypertension, brings out cholelithiasis, pancreatitis, increases the weight of hepatitis, causes the diseases such as male sexual disorder, senile dementia.Therefore, hyperlipemia is not only high any the problem of blood fat, and its seriousness definitely can not be ignored.
Coronary heart disease is the common type that atherosclerosis causes organ lesion, is also the commonly encountered diseases of serious harm people ' s health, is the No.1 killer who threatens human health, and the coronary heart disease death rate accounts for 10%～20% of all deaths from heart disease numbers.The treatment of coronary heart disease generally is divided into Drug therapy, operative treatment and interventional therapy, and wherein Drug therapy is mainly Western medicine, and the active drug for the treatment of by Chinese herbs seldom; The operative treatment risk is larger, and the interventional therapy expense is very expensive, and a lot of family burdens do not rise.
Summary of the invention
The present invention overcomes the deficiencies in the prior art, and technical problem to be solved is to provide and a kind ofly carries, the Chinese medicine composition of effective treatment cardiovascular and cerebrovascular disease of taking convenience.
For solving the problems of the technologies described above; the technical solution adopted in the present invention is: a kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease; the raw material that comprises following weight portion proportioning: Calculus Bovis 0.04-0.07g; Scorpio 0.5-1.5g; Radix Notoginseng 0.8-1.2g, Cornu Saigae Tataricae powder 0.05-0.15g, Eupolyphaga Seu Steleophaga 1-4g; Radix Salviae Miltiorrhizae 0.5-1.5g, Caulis Spatholobi 0.8-1.6g.
As preferred a kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease, comprise the raw material of following weight portion proportioning: Calculus Bovis 0.04-0.05g, Scorpio 0.8-1.2g; Radix Notoginseng 1-1.2g, Cornu Saigae Tataricae powder 0.08-0.12g, Eupolyphaga Seu Steleophaga 2-4g; Radix Salviae Miltiorrhizae 0.8-1.2g, Caulis Spatholobi 1-1.3g.
Described Chinese medicine composition is the enriched pellet agent or is capsule.
Seven flavor medicine is formulated altogether in the present invention.Calculus Bovis GUIXIN liver, bitter in the mouth, property is sweet cool, and function cures mainly relieving convulsion, the function of gallbladder promoting of clearing away heart-fire, reduces phlegm; Radix Notoginseng returns the stomach kidney, and mildly bitter flavor is warm in nature, and function cures mainly dissipating blood stasis, hemostasis, detumescence, analgesic therapy etc.; The Radix Salviae Miltiorrhizae bitter in the mouth, warm in nature, function cures mainly blood circulation promoting and blood stasis dispelling, calming heart and tranquilizing mind, pain relieving, controls angina pectoris; Scorpio returns JUE YIN meridian, and salty in the mouth is cold, and is poisonous, and function cures mainly infantile convulsion, tic, only silt, collateral dredging, detoxifcation, apoplexy etc.; Caulis Spatholobi returns Liver and kidney, and bitter but sweet flavor temperature, function cure mainly and enrich blood, invigorate blood circulation, the meridian dredging; Cornu Saigae Tataricae GUIXIN liver, salty in the mouth, cold in nature, function cures mainly suppressing the hyperactive liver to relieve the wind syndrome, liver heat removing and eyesight improving, loose blood detoxifcation; Eupolyphaga Seu Steleophaga is returned Liver Channel, and salty in the mouth is cold in nature, and is slightly poisonous.
Compared with prior art the beneficial effect that has of the present invention is: the present invention is take Calculus Bovis as monarch drug; be aided with Radix Notoginseng, Scorpio, Cornu Saigae Tataricae powder, Eupolyphaga Seu Steleophaga, Radix Salviae Miltiorrhizae, Caulis Spatholobi; the preparation nature and flavor are proper; return through suitably; the monarch and his subjects are harmonious; to cardiovascular and cerebrovascular disease thrombolytic blood stasis dispelling, relieving convulsion dispeling the wind, vessel softening has the curative effect of highly significant.Several herbal medicines of Chinese medicine composition of the present invention are separately or with the method for steeping in wine or with the method for quench in vinegar or carry element with the method for fire roasting, row nine is changed the number of nine air dry, make pill or capsule, bolus volume is little, dosage is little, side effect is little, carries and take all very convenient.
The specific embodiment
The invention will be further described below in conjunction with specific embodiment.
A kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease of following examples, making becomes enriched pellet agent or capsule, and the efficacy of a drug drug effect of a described pill and capsule is equal to, and the instructions of taking of described pill or capsule is every day three times, each 2-3 grain, one after each meal.
Embodiment 1
A kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease, comprise the raw material of following weight portion proportioning: Calculus Bovis 0.05g, Scorpio 0.5g, Radix Notoginseng 1g, Cornu Saigae Tataricae powder 0.1g, Eupolyphaga Seu Steleophaga 2g, Radix Salviae Miltiorrhizae 1.2g, Caulis Spatholobi 1.4g.
Embodiment 2
A kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease, comprise the raw material of following weight portion proportioning: Calculus Bovis 0.05, Scorpio 0.8g, Radix Notoginseng 0.9g, Cornu Saigae Tataricae powder 0.12g, Eupolyphaga Seu Steleophaga 1g, Radix Salviae Miltiorrhizae 1.5g, Caulis Spatholobi 1.6g.
Embodiment 3
A kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease, comprise the raw material of following weight portion proportioning: Calculus Bovis 0.06g, Scorpio 1.2, Radix Notoginseng 0.8g, Cornu Saigae Tataricae powder 0.08g, Eupolyphaga Seu Steleophaga 2g, Radix Salviae Miltiorrhizae 0.8g, Caulis Spatholobi 0.8g.
Embodiment 4
A kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease, comprise the raw material of following weight portion proportioning: Calculus Bovis 0.04g, Scorpio 1g, Radix Notoginseng 1.2g, Cornu Saigae Tataricae powder 0.15g, Eupolyphaga Seu Steleophaga 3g, Radix Salviae Miltiorrhizae 1g, Caulis Spatholobi 1g.
Embodiment 5
A kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease, comprise the raw material of following weight portion proportioning: Calculus Bovis 0.07g, Scorpio 1.1g, Radix Notoginseng 1g, Cornu Saigae Tataricae powder 0.14g, Eupolyphaga Seu Steleophaga 4g, Radix Salviae Miltiorrhizae 1.3g, Caulis Spatholobi 1.2g.
Embodiment 6
A kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease, comprise the raw material of following weight portion proportioning: Calculus Bovis 0.06g, Scorpio 1.5g, Radix Notoginseng 1.1g, Cornu Saigae Tataricae powder 0.1g, Eupolyphaga Seu Steleophaga 3g, Radix Salviae Miltiorrhizae 0.9g, Caulis Spatholobi 1.3g.
Case 1
Mr. Huang, 67 years old, be diagnosed as coronary atherosclerotic heart disease, labour/spontaneous angina, 3 grades of hypertension, hyperlipidemia on March 22nd, 2010.Treatment routinely, often need to do the PCI intervene operation, body a little less than, be reluctant to accept, then take Chinese medicine composition of the present invention, by each 3, take check after 6 courses for the treatment of (10 days courses for the treatment of) every day for 3 times, fatty liver alleviates, and left room increases, the a small amount of anti-stream of two Tricuspid valvies, left chamber diastolic function reduces.
Case 2
Mr. Zhang, 54 years old, in December, 2012 was diagnosed as coronary atherosclerotic heart disease, exertional angina pectoris, 2 grades of hypertension; Receive 6 courses for the treatment of of Drug therapy of the present invention (10 days courses for the treatment of), front 3 courses for the treatment of are by each 3, take for 3 times every day, rear 3 courses for the treatment of are by each 2, take further consultation in April in this year every day for 3 times, check result is that left room is bigger, left chamber diastolic function lowers, and contractile function is normal, mitral incompetence area 2.7cm
2, long 3.0cm.
The present invention can summarize with other the concrete form without prejudice to spirit of the present invention or principal character.Therefore, no matter from that, above-mentioned embodiment of the present invention all can only be thought can not limit invention to explanation of the present invention, claims have been pointed out scope of the present invention, and scope of the present invention is not pointed out in above-mentioned explanation, therefore, in the implication suitable with claims of the present invention and any variation in scope, all should think to be included in the scope of claims.
Claims (3)
1. Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease, is characterized in that comprising the raw material of following weight portion proportioning: Calculus Bovis 0.04-0.07g, Scorpio 0.5-1.5g; Radix Notoginseng 0.8-1.2g, Cornu Saigae Tataricae powder 0.05-0.15g, Eupolyphaga Seu Steleophaga 1-4g; Radix Salviae Miltiorrhizae 0.5-1.5g, Caulis Spatholobi 0.8-1.6g.
2. a kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease according to claim 1; it is characterized in that comprising the raw material of following weight portion proportioning: Calculus Bovis 0.04-0.05g; Scorpio 0.8-1.2g; Radix Notoginseng 1-1.2g; Cornu Saigae Tataricae powder 0.08-0.12g; Eupolyphaga Seu Steleophaga 2-4g, Radix Salviae Miltiorrhizae 0.8-1.2g, Caulis Spatholobi 1-1.3g.
3. a kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease according to claim 1 and 2, is characterized in that described Chinese medicine composition is the enriched pellet agent or is capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310297384.3A CN103393753B (en) | 2013-07-16 | 2013-07-16 | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310297384.3A CN103393753B (en) | 2013-07-16 | 2013-07-16 | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103393753A true CN103393753A (en) | 2013-11-20 |
| CN103393753B CN103393753B (en) | 2015-03-25 |
Family
ID=49557606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310297384.3A Active CN103393753B (en) | 2013-07-16 | 2013-07-16 | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103393753B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104622930A (en) * | 2015-01-15 | 2015-05-20 | 孙喜翠 | Application of babao (Chinese character) pill in treatment of senile dementia and pharmaceutical composition of babao pill |
| US10772932B2 (en) | 2016-01-29 | 2020-09-15 | Shandong Zhonghai Pharmaceutical CO. LTD | Medicament for use in treating cardiovascular and cerebrovascular diseases |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1580226A (en) * | 2003-08-01 | 2005-02-16 | 王青春 | Medicinal liquor and its preparing method |
| CN101019926A (en) * | 2007-02-13 | 2007-08-22 | 张宗保 | Chinese medicine for treating cardiac and cerebral vascular diseases and its prepn process |
-
2013
- 2013-07-16 CN CN201310297384.3A patent/CN103393753B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1580226A (en) * | 2003-08-01 | 2005-02-16 | 王青春 | Medicinal liquor and its preparing method |
| CN101019926A (en) * | 2007-02-13 | 2007-08-22 | 张宗保 | Chinese medicine for treating cardiac and cerebral vascular diseases and its prepn process |
Non-Patent Citations (2)
| Title |
|---|
| 田军彪等: "补肾活血冲剂治疗老年高血压病肾虚血瘀证90例疗效观察", 《新中医》 * |
| 董顺福等: "治疗心脑血管疾病中成药微量和常量元素含量与疗效的模糊分类法则(英文)", 《中国临床康复》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104622930A (en) * | 2015-01-15 | 2015-05-20 | 孙喜翠 | Application of babao (Chinese character) pill in treatment of senile dementia and pharmaceutical composition of babao pill |
| US10772932B2 (en) | 2016-01-29 | 2020-09-15 | Shandong Zhonghai Pharmaceutical CO. LTD | Medicament for use in treating cardiovascular and cerebrovascular diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103393753B (en) | 2015-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Krup et al. | Pharmacological activities of turmeric (Curcuma longa Linn): a review | |
| CN103705603B (en) | Traditional Chinese medicine for treating acne | |
| CN102727686A (en) | Traditional Chinese medicine composition for treating fatty liver | |
| CN104208245B (en) | Tinea manus and pedis Traditional Chinese medicine medicated bath and preparation method | |
| CN101032580B (en) | Medicine for treating rheumatic diseases | |
| CN103463297B (en) | A kind of Chinese medicine composition for the treatment of eczema scrotum and its production and use | |
| CN103223118B (en) | Traditional Chinese medicine composition for treating facial paralysis | |
| CN103393753B (en) | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases | |
| CN102198175B (en) | Chinese medicine composition | |
| CN101869671A (en) | Paste for waist, leg, shoulder and neck | |
| CN106606592A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN102631425B (en) | Mongolian medicine for treating dyslipidemia | |
| CN101897753B (en) | Traditional Chinese medicine for treating coronary disease and preparation method thereof | |
| CN103920058A (en) | Traditional Chinese medicine preparation for treating headache and preparation method thereof | |
| CN106075229A (en) | A kind of Chinese medicinal composition preparation treating anemopyretic cold | |
| CN104998158A (en) | Pharmaceutical composition for treating liver cirrhosis and application thereof | |
| CN110833615A (en) | A Chinese medicinal composition for treating chronic rhinitis by umbilical therapy, and its preparation method | |
| CN110384785A (en) | A kind of external application Chinese medicine medical fluid and preparation method thereof for treating virus flu | |
| CN103432200B (en) | A kind of medicine for the treatment of Orthopeadic Surgery disease | |
| CN102133274A (en) | Chinese medicinal composition | |
| CN102357160B (en) | Chinese medicine for treating malaria | |
| CN102145079B (en) | Plaster for treating carotid artery freckles and preparation method thereof | |
| CN102274408A (en) | Patch for treating hypertension | |
| CN104606406A (en) | External traditional Chinese medicine unguent for preventing allergic rhinitis and preparation method thereof | |
| CN104399012B (en) | A kind of Chinese medicine composition for primary liver cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |